Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1522282 (
EMT
)
2,868
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Twist has been shown to cause treatment failure, cancer progression, and cancer-related death. However, strategies that directly target Twist are not yet conceivable. Here we reveal that K63-linked ubiquitination is a crucial regulatory mechanism for Twist activation. Through an E3 ligase screen and biochemical studies, we unexpectedly identified that
RNF8
functions as a direct Twist activator by triggering K63-linked ubiquitination of Twist.
RNF8
-promoted Twist ubiquitination is required for Twist localization to the nucleus for subsequent
EMT
and CSC functions, thereby conferring chemoresistance. Our histological analyses showed that
RNF8
expression is upregulated and correlated with disease progression,
EMT
features, and poor patient survival in breast cancer. Moreover,
RNF8
regulates cancer cell migration and invasion and cancer metastasis, recapitulating the effect of Twist. Together, our findings reveal a previously unrecognized tumor-promoting function of
RNF8
and provide evidence that targeting
RNF8
is an appealing strategy to tackle tumor aggressiveness and treatment resistance.
...
PMID:The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation. 2761 86
Breast cancer is the leading cause of cancer-associated deaths among females. In recent decades, microRNAs (miRNAs), a type of short non-coding RNA that regulates gene expression at the post-transcription level, have been reported to participate in the regulation of many hub genes associated with tumorigenesis, tumor progression, and metastasis. However, the precise mechanism by which miRNAs regulate breast cancer metastasis remains poorly discussed, which limits the opportunity for the development of novel, effective therapeutic targets. Here, we aimed to determine the miR-622-related principal regulatory mechanism in cancer. First, we found that miR-622 was significantly related to a poor prognosis in various cancers. By utilizing an integrated miRNA prediction process, we identified 77 promising targets and constructed a protein-protein interaction network. Furthermore, enrichment analyses, including GO and KEGG pathway analyses, were performed to determine the potential function of miR-622, which revealed regulation networks and potential functions of miR-622. Then, we identified a key cluster comprised of six hub genes in the protein-protein interaction network. These genes were further chosen for pan-cancer expression, prognostic and predictive marker analyses based on the TCGA and GEO datasets to mine the potential clinical values of these hub genes. To further validate our bioinformatic results, the regulatory axis of miR-622 and
RNF8
, one of the hub genes recently reported to promote breast cancer cell
EMT
process and breast cancer metastasis, was selected as
in vitro
proof of concept.
In vitro
, we demonstrated the direct regulation of
RNF8
by miR-622 and found that the predicted miR-622-
RNF8
axis could regulate
RNF8
-induced epithelial-mesenchymal transition, cell migration, and cell viability. These results were further demonstrated with rescue experiments. We established a closed-loop miRNA-target-phenotype research model that integrated the bioinformatic analysis of the miRNA target genes and experimental validation of the identified key miRNA-target-phenotype axis. We not only identified the hub target genes of miR-622
in silico
but also revealed the regulatory mechanism of miR-622 in breast cancer cell
EMT
process, viability, and migration
in vitro
for the first time.
...
PMID:Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer. 3170 82
RNF8
(
ring finger protein 8
), a RING finger E3 ligase best characterized for its role in DNA repair and sperm formation via ubiquitination, has been found to promote tumor metastasis in breast cancer recently. However, whether
RNF8
also plays a role in other types of cancer, especially in lung cancer, remains unknown. We show here that
RNF8
expression levels are markedly increased in human lung cancer tissues and negatively correlated with the survival time of patients. Overexpression of
RNF8
promotes the
EMT
process and migration ability of lung cancer cells, while knockdown of
RNF8
demonstrates the opposite effects. In addition, overexpression of
RNF8
activates the PI3K/Akt signaling pathway, knockdown of
RNF8
by siRNA inhibits this activation, and pharmacologic inhibition of PI3K/Akt in
RNF8
-overexpressing cells also reduces the expression of
EMT
markers and the ability of migration. Furthermore,
RNF8
is found to directly interact with Slug and promoted the K63-Ub of Slug, and knockdown of Slug disrupts
RNF8
-dependent
EMT
in A549 cells, whereas overexpression of Slug rescues
RNF8
-dependent MET in H1299 cells, and depletion of
RNF8
expression by shRNA inhibits metastasis of lung cancer cells
in vivo
. Taken together, these results indicate that
RNF8
is a key regulator of
EMT
process in lung cancer and suggest that inhibition of
RNF8
could be a useful strategy for lung cancer treatment. IMPLICATIONS: This study provides a new mechanistic insight into the novel role of
RNF8
and identifies
RNF8
as a potential new therapeutic target for the treatment of lung cancer.
...
PMID:RNF8 Promotes Epithelial-Mesenchymal Transition in Lung Cancer Cells via Stabilization of Slug. 3275 72
The ubiquitin ligase
RNF8
is known to induce epithelial-to-mesenchymal (
EMT
) transition and metastasis in triple-negative breast cancer (TNBC). Besides
EMT
, Rho GTPases have been shown as key regulators in metastasis. In this study, we investigated the role of
RNF8
in regulating Rho GTPases and cell motility. We find that
RNF8
knockdown in TNBC cells attenuates the protein and mRNA levels of Ras homolog family member A (RHOA) and cell division cycle 42 (CDC42). We show that the formation of filopodia, focal adhesions, and the association of focal adhesions to stress fibers is impaired upon
RNF8
knockdown. Cell migration is significantly inhibited by
RNF8
knockdown. Our study suggests a potential novel role for
RNF8
in mediating cell migration in TNBC through regulation of the Rho GTPases RHOA and CDC42.
...
PMID:The ubiquitin ligase RNF8 regulates Rho GTPases and promotes cytoskeletal changes and motility in triple-negative breast cancer cells. 3320 15